Accelovance, Inc. (extinct)

Accelovance, Inc. (extinct)

Accelovance, Inc. (extinct)

Overview
Date Founded

2004

Headquarters

2275 Research Boulevard,Suite 700,Rockville, MD 20850

Type of Company

Private

Industries

Other Business & Consulting Services
Medical Products & Equipment

Company Description

Accevolance, Inc. engages in providing clinical research and development services. It operates through the following core service divisions: Full-Service CRO, Patient Recruitment, and Clinical Call Center. The Full-Service CRO division includes protocol development, project management, clinical trial monitoring, data management, Biostatistics, Pharmacovigilance, regulatory affairs, and medical writing. The Patient Recruitment division involves patient recruitment and management. The Clinical Call Center division provides recruitment, retention, and compliance; post approval safety studies; Phase IV studies; surveillance programs; patient-reported outcomes; observational studies; registries; site support services; patient market research; and risk management support. The company was founded by Stephen J. Trevisan in 2005 and is headquartered in Rockville, MD.

Contact Data
Trying to get in touch with decision makers at Accelovance, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Paths to Accelovance, Inc.
Potential Connections via
Relationship Science
You
Accelovance, Inc.
Recent Transactions
Details Hidden

Linical Co., Ltd., Linical USA, Inc. purchase Accelovance, Inc.

Details Hidden

Accelovance, Inc., Accelovance Europe Holding Ltd. purchase Therametrics Holding AG /(4) Subsidiaries from THERAMetrics holding AG

Details Hidden

Accelovance, Inc. purchases Clinquest Group BV /2 Subs from Clinquest Group BV

Transaction Advisors
Investment Advisor

Advised onLinical Co., Ltd., Linical USA, Inc. purchase Accelovance, Inc.

Founder & Chief Executive Officer

Advised onLinical Co., Ltd., Linical USA, Inc. purchase Accelovance, Inc.

Clients

Advanced Accelerator Applications SA is a radiopharmaceutical company, which develops, produces and commercializes molecular nuclear medicine products. It offers research and development in medicinal and pharmaceutical therapeutic products mainly focusing in cardiology and neurology. The company manufactures both diagnostic and therapeutic MNM products for commercialization. Advanced Accelerator Applications was founded in 2002 by Stefano Buono and is headquartered in Saint Genis Pouilly, France.

Suppliers
Veeva Systems, Inc. Other Business & Consulting Services | Pleasanton, CA

Veeva Systems, Inc. engages in the provision of industry-specific, cloud-based software solutions for the life sciences industry. Its solutions enable pharmaceutical and other life sciences companies to realize the benefits of modern cloud-based architectures and mobile applications for their most critical business functions, without compromising industry-specific functionality or regulatory compliance. The firm's customer relationship management solutions enable its customers to increase the productivity and compliance of their sales and marketing functions. Its regulated content management and collaboration solutions enable its customers to more efficiently manage a regulated, content-centric processes across the enterprise. The company's customer master solution enables customers to more effectively manage complex healthcare provider and healthcare organization data. The company was founded by Mark Armenante, Peter P. Gassner, Doug Ostler, Mitch Wallace and Matthew J. Wallach on January 12, 2007 and is headquartered in Pleasanton, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Accelovance, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Accelovance, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Accelovance, Inc..